Kayyem Jon Faiz

Kayyem Jon Faiz is listed in filings as Director at Inhibrx Biosciences, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including purchase activity. Recent filings connect the profile to Inhibrx Biosciences, Inc. (INBX) and Biodesix, Inc. (BDSX). The current snapshot covers public activity from Nov 22, 2024 to Jun 4, 2026. Reported amounts are shown as $495.7K to $193.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.